======= PHF17 =======
== Gene Information ==
* **Official Symbol**: JADE1
* **Official Name**: jade family PHD finger 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79960|79960]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q6IE81|Q6IE81]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PHF17&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PHF17|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/610514|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|EPL1|
|PHD|
|histone H4-K12 acetylation|
|histone H4-K8 acetylation|
|histone H4-K5 acetylation|
|histone H4-K16 acetylation|
|histone acetyltransferase complex|
|histone H3 acetylation|
|histone H4 acetylation|
|negative regulation of G1/S transition of mitotic cell cycle|
|negative regulation of cell cycle G1/S phase transition|
|histone acetylation|
|internal peptidyl-lysine acetylation|
|peptidyl-lysine acetylation|
|internal protein amino acid acetylation|
|ciliary basal body|
|protein acetylation|
|regulation of G1/S transition of mitotic cell cycle|
|regulation of cell cycle G1/S phase transition|
|negative regulation of canonical Wnt signaling pathway|
|negative regulation of cell growth|
|protein acylation|
|negative regulation of Wnt signaling pathway|
|negative regulation of mitotic cell cycle phase transition|
|negative regulation of cell cycle phase transition|
|negative regulation of growth|
|regulation of canonical Wnt signaling pathway|
|transcription coactivator activity|
|negative regulation of mitotic cell cycle|
|peptidyl-lysine modification|
|negative regulation of cell cycle process|
|regulation of Wnt signaling pathway|
|histone modification|
|covalent chromatin modification|
|nuclear speck|
|regulation of mitotic cell cycle phase transition|
|regulation of cell growth|
|regulation of cell cycle phase transition|
|negative regulation of cell cycle|
|regulation of mitotic cell cycle|
|regulation of growth|
|chromatin organization|
|regulation of cell cycle process|
|peptidyl-amino acid modification|
|apoptotic process|
|programmed cell death|
|chromosome organization|
|cell death|
|regulation of cell cycle|
|negative regulation of signal transduction|
|negative regulation of cell communication|
|negative regulation of signaling|
|negative regulation of response to stimulus|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of RNA metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-2.13|
|[[:results:exp30|Rapamycin 10μM R00 exp30]]|-1.79|
|[[:results:exp256|HMS-I1 10μM R06 exp256]]|-1.72|
|[[:results:exp261|ABT-702 5μM R06 exp261]]|-1.71|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4194
* **Expression level (log2 read counts)**: 7.01
{{:chemogenomics:nalm6 dist.png?nolink |}}